Correlation Between Acumen Pharmaceuticals and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Eliem Therapeutics, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Eliem Therapeutics.
Diversification Opportunities for Acumen Pharmaceuticals and Eliem Therapeutics
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Acumen and Eliem is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between Acumen Pharmaceuticals and Eliem Therapeutics
Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to generate 0.87 times more return on investment than Eliem Therapeutics. However, Acumen Pharmaceuticals is 1.15 times less risky than Eliem Therapeutics. It trades about -0.05 of its potential returns per unit of risk. Eliem Therapeutics is currently generating about -0.17 per unit of risk. If you would invest 294.00 in Acumen Pharmaceuticals on August 25, 2024 and sell it today you would lose (57.00) from holding Acumen Pharmaceuticals or give up 19.39% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 98.46% |
| Values | Daily Returns |
Acumen Pharmaceuticals vs. Eliem Therapeutics
Performance |
| Timeline |
| Acumen Pharmaceuticals |
| Eliem Therapeutics |
Acumen Pharmaceuticals and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acumen Pharmaceuticals and Eliem Therapeutics
The main advantage of trading using opposite Acumen Pharmaceuticals and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.| Acumen Pharmaceuticals vs. Eliem Therapeutics | Acumen Pharmaceuticals vs. HCW Biologics | Acumen Pharmaceuticals vs. Scpharmaceuticals | Acumen Pharmaceuticals vs. Milestone Pharmaceuticals |
| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |